The correction of leg-length discrepancy after treatment in developmental dysplasia of the hip by using a percutaneous epiphysiodesis.

The correction of leg-length discrepancy after treatment in developmental dysplasia of the hip by using a percutaneous epiphysiodesis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

The correction of leg-length discrepancy after treatment in developmental dysplasia of the hip by using a percutaneous epiphysiodesis. Abstract Text:

Muharrem Inan,Gilbert Chan,James Richard Bowen,

The aims of this study were to determine factors that cause a leg-length discrepancy (LLD) to the extent that correction is indicated after treatment in developmental dysplasia of the hip and determine whether the LLD may be treated with a percutaneous epiphysiodesis. Twelve children were included in this study. The factors which caused LLD were avascular necrosis, femoral shortening and varus at reduction, and septic arthritis. Percutaneous epiphysiodesis of the contralateral limb reduced the mean predicted LLD from 3.8 to 1.2 cm at maturity. We concluded that LLD (>2.5 cm) might result from complications of developmental dysplasia of the hip and these patients can be treated with a percutaneous epiphysiodesis.

The correction of leg-length discrepancy after treatment in developmental dysplasia of the hip by using a percutaneous epiphysiodesis. Publishing Authors By Initials

M Inan,G Chan,JR Bowen,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

The correction of leg-length discrepancy after treatment in developmental dysplasia of the hip by using a percutaneous epiphysiodesis. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of pediatric orthopaedics. Part B / Europe

VOLUME: 17

Page Numbers: 43-6

Journal Abbreviation:

ISSN: 1060-152X

DAY: 28

MONTH: Jan

YEAR: 2008

The correction of leg-length discrepancy after treatment in developmental dysplasia of the hip by using a percutaneous epiphysiodesis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9300904

The correction of leg-length discrepancy after treatment in developmental dysplasia of the hip by using a percutaneous epiphysiodesis. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: The correction of leg-length discrepancy after treatment in developmental dysplasia of the hip by using a percutaneous epiphysiodesis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for The correction of leg-length discrepancy after treatment in developmental dysplasia of the hip by using a percutaneous epiphysiodesis.

AFFILIATION: aDepartment of Orthopedics, AI. duPont Hospital for Children, Wilmington, Delaware, USA bDepartment of Orthopaedics Yeditepe University, Istanbul, Turkey.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Pediatr Orthop B

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

The correction of leg-length discrepancy after treatment in developmental dysplasia of the hip by using a percutaneous epiphysiodesis Related Publications

• Acute onset left hemiparesis and facial droop in a 37 year old soccer player: 1123: june 1 3:15 PM - 3:35 PM.
• C1584 in von Willebrand factor is necessary for enhanced proteolysis by ADAMTS13 in vitro.
• Chain of custody as an organizing framework in seafood risk reduction.
• Complex palliative care and transition: a case review.
• Decontaminable surfaces for millicurie-level laboratories.
• Determination of cell colony formation in a high-content screening assay.
• Duplications involving int22h-1 of the factor VIII gene: a cause for concern in genetic testing for hemophilia A?
• Dynamics of passive immunity to West Nile virus in domestic chickens (Gallus gallus domesticus).
• Electron-cytochemical localization of acid phosphatase activity in the digestive caeca of the desert locust.
• Failure to induce an antiviral state in preimplantation bovine embryos treated with interferon.
• Health impact assessments in London: assessing the London Mayoral strategies.
• Increases in amphetamine-like discriminative stimulus effects of the abused inhalant toluene in mice.
• MR angiography versus CT angiography in the evaluation of neurovascular disease.
• Methods and normal values for echocardiography in adult dairy cattle.
• Photoelectron spectroscopy of hydrated adenine anions.
• Predictors of self-referral into a cancer genetics registry.
• Raloxifene and selective cell cycle specific agents: a case for the inclusion of raloxifene in current breast cancer treatment therapies.
• Results of a randomized study of telephone versus in-person breast cancer risk counseling.
• Salivary glucosyltransferase B as a possible marker for caries activity.
• Self-rated breast cancer risk among women reporting a first-degree family history of breast cancer on office screening questionnaires in routine medical care: the role of physician-delivered risk feedback.
• Sequence-dependent administration of raloxifene and 5-fluorouracil/pemetrexed protects against pemetrexed cytotoxicity in human bone marrow.
• Sequential combination chemotherapy in human breast cancer: a basis for increased antineoplastic activity and bone marrow protection.
• Solenopsin, the alkaloidal component of the fire ant (Solenopsis invicta), is a naturally occurring inhibitor of phosphatidylinositol-3-kinase signaling and angiogenesis.
• The cancer worry chart: a single-item screening measure of worry about developing breast cancer.
• The correction of leg-length discrepancy after treatment in developmental dysplasia of the hip by using a percutaneous epiphysiodesis.
• The effects of methyltestosteone on reproductive function in male greyhounds.
• The effects of prostalene and alfaprostol as uterine myotonics, and the effect on postpartum pregnancy rate in the mare following daily treatment with prostalene.
• The impact of HIV-related interventions on HIV risk behavior in a community sample of African American crack cocaine users.
• The protection against trimetrexate cytotoxicity in human bone marrow by sequence-dependent administration of raloxifene, 5-fluorouracil/trimetrexate.
• Use of the statistical properties of the wavelet-transform coefficients for optimization of integration time in Fourier transform spectrometry.